Core Viewpoint - Owlet's stock experienced a significant decline of over 33% following the company's disappointing first-quarter sales outlook, which projected $20.5 million, falling short of the expected $26.2 million [1][1][1] Group 1: Financial Performance - The company reported fourth-quarter sales of $26.6 million, exceeding expectations of $26 million, although it still posted losses that were narrower than anticipated [1][1] - Year-over-year sales for the first quarter are expected to decrease by 3% at the midpoint, indicating a challenging market environment [1][1] Group 2: Market Dynamics - Weaker consumer spending during the holiday season and macroeconomic uncertainties have led retailers to reduce inventory levels, negatively impacting Owlet's sales [1][1] - The first quarter is projected to account for only 16% of total sales forecasts this year, down from 20% last year, placing increased pressure on the latter half of the year to perform better [1][1] Group 3: Growth Initiatives - Owlet has increased its paying Owlet360 subscribers to 110,000 as of early March, indicating positive growth in its subscription service [1][1] - The company plans to launch Owlet OnCall, a telehealth platform, in the second half of the year, which is expected to enhance its pediatric health offerings [1][1] - Registry additions for the Dream Sock increased by 23% year-over-year in the fourth quarter, suggesting growing consumer interest [1][1]

Financial Data and Key Metrics Changes - Owlet achieved record annual revenue of $105.7 million for 2025, representing a 35.4% increase over 2024 [10][24] - Q4 2025 revenue was $26.6 million, up 29.6% year-over-year, driven by growth across the Dream product suite and Owlet360 subscription [10][23] - Full year 2025 gross margin was a record 50.6%, despite a 510 basis point impact from tariffs [10][24] - Adjusted EBITDA for Q4 was $0.1 million, down from $0.5 million in Q4 2024, while full year Adjusted EBITDA reached $2 million, a $3.8 million improvement over 2024 [10][11][25] Business Line Data and Key Metrics Changes - The Owlet360 subscription service crossed 110,000 paying subscribers, contributing to the company's long-term business strategy [5][17] - Dream Sock and Duo demonstrated strong domestic year-over-year sell-through at 9% and 53% respectively, indicating robust demand [12] - The introduction of the Dream Sight camera is expected to enhance customer lifetime value (LTV) and drive subscriber growth [7][11] Market Data and Key Metrics Changes - Owlet expanded its market share in baby monitors to 41% in Q4 2025, a 24% increase compared to Q4 2024 [13] - International revenue for Q4 reached $3.9 million, totaling $19.2 million for the year, a 27% increase over 2024 [14] - Strong sell-through was observed in international markets, with the U.K. up 58%, France up 41%, and the Nordics up 80% versus Q4 2024 [15] Company Strategy and Development Direction - The company aims to drive global adoption of Dream Sock, expand the Owlet360 subscription platform, grow healthcare channels, and launch the Owlet telehealth platform [11][19] - Owlet is focusing on integrating AI across its platforms to enhance competitive edge and support parents [18] - The company is positioned to redefine modern parenting by establishing a comprehensive pediatric health monitoring platform [65] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in strong performance and growth into 2026, despite challenges such as tariffs and macroeconomic pressures [11][30] - The company anticipates another record year of growth in 2026, with revenue expected to be in the range of $126 million to $130 million, representing a 19%-23% increase over 2025 [28][30] - The first quarter of 2026 is expected to be the lowest revenue contributor due to seasonality, but management remains optimistic about long-term demand [33][30] Other Important Information - The company simplified its capital structure and strengthened its balance sheet through a successful equity offering [8] - Owlet's telehealth platform is expected to launch in the second half of 2026, enhancing care quality and patient outcomes [20][47] Q&A Session Summary Question: Guidance for Q1 and revenue expectations - Management noted that Q1 is historically the lightest revenue contributor and that current macroeconomic conditions have influenced consumer spending [33][34] Question: Generative AI insights and their impact - The company sees a significant opportunity to leverage AI for personalized parenting support and to enhance subscription features [36] Question: International expansion and subscription progress - Management expects international revenue to begin in the first half of the year and is excited about the potential for subscription growth in new markets [41] Question: Go-to-market strategy for telehealth offering - The telehealth platform will be an upsell to Owlet360, with a focus on refining the user experience before the full launch [47] Question: Churn rate for Owlet360 subscribers - Management reported positive trends in subscriber growth and retention rates, with plans to share more data in future calls [50]

Financial Data and Key Metrics Changes - Owlet achieved record annual revenue of $105.7 million for 2025, representing a 35.4% increase compared to 2024 [10][24] - Q4 2025 revenue was $26.6 million, up 29.6% year-over-year, driven by growth across the Dream product suite and Owlet360 subscription [10][23] - Full year 2025 gross margin was a record 50.6%, despite a 510 basis point impact from tariffs [10][24] - Adjusted EBITDA for Q4 was $0.1 million, down from $0.5 million in Q4 2024, while full year 2025 Adjusted EBITDA reached a record $2 million, improving by $3.8 million over 2024 [10][11][25] Business Line Data and Key Metrics Changes - The Owlet360 subscription service crossed 110,000 paying subscribers, contributing to the company's growth strategy [5][17] - Dream Sock and Duo demonstrated strong domestic year-over-year sell-through at 9% and 53% respectively, indicating robust demand [12] - International revenue for Q4 reached $3.9 million, with full year 2025 international revenue at $19.2 million, up 27% versus 2024 [14][15] Market Data and Key Metrics Changes - Owlet expanded its market share in baby monitors to 41% in Q4 2025, a 24% increase compared to Q4 2024 [13] - Consumer spending on baby monitors in 2025 was the highest in the last five years, indicating a growing market [13] - International sell-through remains strong, with significant growth in the U.K. (58%), France (41%), and the Nordics (80%) compared to Q4 2024 [15] Company Strategy and Development Direction - The company aims to drive global adoption of Dream Sock, expand the Owlet360 subscription platform, grow healthcare channels, and launch the Owlet telehealth platform [11][19] - Owlet is focusing on integrating AI across its platforms to enhance its competitive edge and improve customer experiences [18] - The company is positioned to capture the Gen Z and young millennial demographic, where connected wearable devices are already a baseline expectation [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in strong performance and growth into 2026, despite challenges such as tariffs and macroeconomic pressures [11][30] - The company anticipates revenue for Q1 2026 in the range of $20 million-$21 million, with full year 2026 revenue expected to be between $126 million-$130 million, representing growth of 19%-23% over 2025 [27][28] - Management highlighted the importance of the pediatric telehealth opportunity, which could significantly enhance care quality and patient outcomes [20] Other Important Information - Owlet's cash and cash equivalents as of December 31, 2025, were $35.5 million, up from $23.8 million in the previous quarter [26] - The company has received regulatory clearance for Dream Sock sales in India and Israel, expanding its international growth potential [15][16] Q&A Session Summary Question: Guidance for Q1 and full year expectations - Management noted that Q1 is typically the lightest revenue contributor due to seasonality and observed softness in consumer spending [33] - Confidence in the full year guidance reflects strong long-term demand despite a lighter Q1 [34] Question: Generative AI insights and their impact - Management discussed leveraging AI for real-time personalized insights and enhancing subscription features, which will drive stickiness [36] Question: International expansion and subscription progress - Management expects international revenue to begin in the first half of the year, with strong sell-through in European markets [41] - The guidance does not include material contributions from new countries or telehealth opportunities, indicating potential upside [42] Question: Go-to-market strategy for telehealth offering - The telehealth platform will be an upsell to Owlet360, with a focus on getting the experience right before launching in the second half of 2026 [47] Question: Churn rate for Owlet360 subscribers - Management reported positive trends in subscriber growth, retention, and metrics indicating improved stickiness [50] Question: Long-term view on international revenue - Management sees significant growth opportunities in international markets, particularly in regions with high birth rates [59]

Financial Data and Key Metrics Changes - Owlet achieved revenue of $26.6 million in Q4 2025, a 29.6% increase compared to Q4 2024, concluding a record year with total revenue of $105.7 million for 2025, representing a 35.4% growth over 2024 [9][22] - Q4 gross margins were 47.6%, impacted by tariffs, while full year 2025 gross margins reached a record 50.6% [9][23] - Adjusted EBITDA for Q4 was $0.1 million, down from $0.5 million in Q4 2024, while full year 2025 Adjusted EBITDA was a record $2 million, improving by $3.8 million over 2024 [10][24] Business Line Data and Key Metrics Changes - The Owlet360 subscription service crossed 110,000 paying subscribers, contributing to revenue growth and enhancing customer relationships [5][15] - The Dream product suite, including the new Dream Sight camera, showed strong sales momentum, with Dream Sock and Duo experiencing year-over-year sell-through increases of 9% and 53% respectively [11][12] Market Data and Key Metrics Changes - Owlet expanded its market share in the baby monitor category to 41% in Q4 2025, a 24% increase compared to Q4 2024, with overall consumer spending on baby monitors at a five-year high [12] - International revenue reached $3.9 million in Q4, totaling $19.2 million for the year, a 27% increase from 2024, despite a decline in Q4 due to a shift in revenue recognition [13] Company Strategy and Development Direction - The company aims to drive global adoption of Dream Sock, expand the Owlet360 subscription platform, grow healthcare channels, and launch the Owlet telehealth platform [10][18] - Owlet is focusing on integrating AI across its platforms to enhance its competitive edge and provide personalized experiences for parents [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in strong performance and growth into 2026, despite challenges such as tariff impacts and macroeconomic pressures [10][28] - The company anticipates another record year in 2026, with revenue expectations between $126 million and $130 million, representing a growth of 19%-23% over 2025 [27] Other Important Information - Owlet's cash and cash equivalents were $35.5 million at the end of Q4, up from $23.8 million in Q3, indicating improved liquidity [25] - The company is investing in R&D to enhance software and services for its subscription and telehealth offerings [27] Q&A Session Summary Question: Guidance for Q1 and revenue expectations - Management noted that Q1 is typically the lowest revenue quarter due to seasonality and a strong prior year, but remains confident in long-term demand [31][33] Question: Details on generative AI insights - The company plans to leverage AI for personalized sleep coaching and actionable insights, enhancing the subscription features [34][35] Question: International expansion and subscription progress - Revenue from new international markets is expected to begin in the first half of the year, with strong sell-through in existing European markets [39][40] Question: Go-to-market strategy for telehealth offering - The telehealth platform will be an upsell to Owlet360, with a focus on refining the user experience before a full launch [44] Question: Churn rate for Owlet360 subscribers - Management reported improving retention rates and positive trends in subscriber metrics, indicating strong customer engagement [47]

Owlet, Inc. (NYSE: OWLT) Q4 & FY 2025 Financial Results March 5, 2026 March 4, 2025 2026 Confidential | 2 Owlet, Inc. (NYSE: OWLT) | Q4 2025 Financial Results Conference Call Speakers Webcast Contacts ● Jonathan Harris, President & CEO ● Amanda Twede Crawford, CFO ● Jay Gentzkow, VP Investor Relations and Corporate Development ● Domestic Callers: (833) 470-1428 ● International Callers: (404) 975-4839 ○ Access Code: 211338 ● Webcast Archive Available: investors.owletcare.com ● Website: investors.owletcare.co ...

Core Insights - Remote and continuous patient monitoring is becoming essential in modern healthcare due to aging populations, staffing shortages, and a shift towards data-driven care [1] - Owlet, Inc. and Masimo Corporation represent two distinct investment approaches within the same trend, focusing on different patient demographics and stages of business maturity [2] Owlet Stock Analysis - Owlet is transitioning from a hardware-focused company to a pediatric digital health platform with recurring revenue potential, achieving record revenue growth of approximately 45% year over year in Q3 2025 [4] - The Dream Sock is the first FDA-cleared over-the-counter infant monitoring device, enhancing brand trust and market share, with recent international expansion into India [5] - Owlet's subscription platform, Owlet360, has over 85,000 paying subscribers, with plans to integrate AI-driven insights and telehealth capabilities, potentially reshaping its earnings profile [6] - Challenges include tariff impacts on gross margins and the need for sustained investment in healthcare-channel reimbursement and telehealth partnerships [7] Masimo Stock Analysis - Masimo is a leader in noninvasive monitoring technologies, focusing on recurring consumables and long-term contracts, with preliminary full-year revenue of approximately $1.52 billion in 2025 [9] - The company is refocusing on core healthcare operations post-divestiture of its consumer-audio business, with strong contract wins and rising demand for advanced monitoring solutions [10] - Masimo expanded operating margins by 450 basis points year over year in Q3 2025, supported by strong cash flow generation and share repurchases totaling around $350 million [11] - Growth expectations for 2026 are modest, with revenue growth projected in the mid-single-digit range, reflecting maturity and hospital budget constraints [12] Market Performance Comparison - Over the past six months, Owlet shares increased by 71.5%, while Masimo shares decreased by 11.7%, indicating contrasting investor sentiment [13] - Owlet trades at a forward price-to-sales ratio of approximately 1.75X, significantly lower than Masimo's 4.54X, suggesting potential upside for Owlet if growth continues [18] Earnings Estimates - Owlet's 2026 loss per share estimate has improved from 48 cents to 25 cents, with projected revenue growth of 21.1% [20] - Masimo's 2026 EPS estimate is $5.77, reflecting steady but slower growth of about 5.9%, with revenues expected to rise 6.6% [22] Investment Outlook - Owlet offers a compelling growth trajectory with regulatory differentiation and an expanding subscription base, while Masimo provides stability and predictable cash flows [25] - Owlet is rated as a Zacks Rank 1 (Strong Buy), indicating superior upside potential compared to Masimo, which holds a Rank 2 (Buy) [25]

Core Insights - Owlet, Inc. (OWLT) is expanding its product ecosystem to address a wider range of infant monitoring needs beyond a single-device offering [1] - The company is focusing on pairing wearable and camera-based devices to provide a comprehensive view of infant wellness [2] Product Development - In Q3 2025, Owlet launched the Dream Sight camera, its third-generation video baby monitor, featuring enhanced security and capabilities for future expansion [3] - Bundled offerings, such as combining the Dream Sock with camera products, are being emphasized to encourage multi-device adoption and create additional sales opportunities [4] Market Position and Competition - The competitive landscape in connected infant monitoring is intense, with companies like Masimo and iRhythm Technologies shaping adjacent markets [6] - Owlet's strategy of combining wearable and camera devices targets a specific niche in infant monitoring, which could enhance household adoption if executed effectively [9] Financial Performance - Owlet's shares have increased by 77.1% over the past six months, outperforming the Zacks Electronics - Miscellaneous Products industry's growth of 30.1% and the Zacks Computer and Technology sector's rise of 15.9% [10] - The Zacks Consensus Estimate for OWLT's 2026 loss has narrowed to 25 cents from 48 cents in the past 30 days, with an expected loss of 12 cents per share in 2025 [13]

Core Insights - Owlet, Inc. (OWLT) has experienced a significant stock performance, with shares increasing over 82% in the past six months, outperforming various industry benchmarks [1][6][25] Group 1: Financial Performance - The company reported record revenue and its first operating profit in Q3, with gross margins exceeding 50% [6][8] - The stock is currently trading at approximately $15.83, above its 50-day and 200-day moving averages, indicating a sustained uptrend [5][6] - Revenue growth is driven by strong demand for the Dream Sock franchise and the launch of the Dream Sight camera [8] Group 2: Regulatory Environment - Owlet is the first and only FDA-cleared over-the-counter infant monitoring device, enhancing its brand credibility and creating barriers to entry for competitors [9][10] - Recent FDA communications cautioning against unauthorized infant monitors further solidify Owlet's competitive edge [9][10] Group 3: Subscription and Platform Expansion - The company is expanding its recurring revenue through the Owlet360 subscription, with over 85,000 paying subscribers and attach rates exceeding 25% [11] - Future plans include piloting generative AI features for personalized sleep insights, aimed at increasing customer engagement and lifetime value [12] Group 4: International and Healthcare Growth - International revenue saw significant growth, with regulatory approval in India expected to open a large market in early 2026 [13][15] - The company is making strides in healthcare channels, with hospital partnerships and remote patient monitoring initiatives that could expand its addressable market [15] Group 5: Valuation and Market Position - Despite the stock's rise, Owlet's valuation remains modest compared to the broader technology sector, suggesting potential for further appreciation [16] - Recent estimate revisions indicate growing confidence in Owlet's path toward sustained profitability, with revenue estimates projecting 21.1% growth [17] Group 6: Competitive Landscape - Owlet faces competition from companies like Masimo, iRhythm Technologies, and Koninklijke Philips, but its focus on FDA-cleared consumer hardware and a subscription ecosystem differentiates it [19][24]

Core Insights - Owlet, Inc. is transitioning from a connected baby monitor brand to a data-driven pediatric health platform, leveraging a growing dataset of infant health and sleep data from over 650,000 active devices and 85,000 paying Owlet360 subscribers [1][10] Data Flywheel and Monetization - The expanding dataset enhances Owlet's flywheel by increasing device adoption, which feeds more biometric and behavioral data into the platform, leading to improved insights and feature development [2] - Richer insights from the dataset increase the value of Owlet360, resulting in higher subscription attach rates, which have surpassed 25%, indicating early success in monetizing data [2] AI Integration - Owlet plans to incorporate AI-driven insights across its ecosystem, combining biometric data from Dream Sock with computer vision from the Dream Sight camera to provide personalized guidance on infant sleep and wellness [3] - The company aims to pilot generative AI features in early 2026, including tailored sleep coaching based on individual child patterns, which could enhance engagement and extend subscriptions beyond infancy [3] Long-term Healthcare Ambitions - The data flywheel supports Owlet's long-term goals in healthcare, including remote patient monitoring and telehealth initiatives, which could open higher-value channels beyond consumer hardware [4] Competitive Landscape - Masimo and Dexcom are relevant comparables, with Masimo focusing on clinically validated sensors and algorithms to drive decision support, while Dexcom monetizes continuous data streams through recurring revenue and analytics [6][7] - Both companies demonstrate how data scale and AI integration can significantly enhance lifetime value, a target for Owlet as it develops its dataset and AI capabilities [7] Financial Performance - Owlet's shares have increased by 73.3% over the past six months, outperforming the Zacks Electronics - Miscellaneous Products industry's growth of 20.6% and the Zacks Computer and Technology sector's rise of 19.1% [8] - The Zacks Consensus Estimate for Owlet's 2026 loss has improved to 25 cents from 88 cents in the past month, with an expected loss of 12 cents per share in 2025 [12]

Core Viewpoint - Owlet (OWLT) is a digital parenting platform valued at $250 million, providing real-time data and insights to assist parents in monitoring their infants' health [1] Product Overview - The flagship product, Dream Sock, is a wearable health monitor that uses pulse oximetry technology to track vital signs such as pulse rate, oxygen levels, and sleep patterns [2] Technical Analysis - OWLT has shown strong technical momentum, trading at a new 3-year high of $15.20, with shares up 200% over the past year [6][7] - The stock gained 53.51% since the Trend Seeker "Buy" signal was issued on November 11 [3] - The Relative Strength Index (RSI) is at 79.78, indicating strong momentum [7] - A technical support level is identified around $14 [7] Market Sentiment - Owlet maintains a 100% "Buy" opinion from Barchart and is rated a "Strong Buy" by Wall Street [6][7] - However, Morningstar suggests the stock is currently overvalued by 10% following its recent price increase [6] Financial Projections - Revenue is projected to grow by 33.97% this year and an additional 22.11% next year [7] - Earnings are estimated to decrease by 534.72% this year but are expected to rebound by 75.05% next year [8] Investor Interest - Wall Street has begun to take notice of OWLT, while individual investors are just starting to recognize the stock [9]